Company intelligence / Profile preview

SkinnyRx

Miami, Florida, United States

Ownership: Private
Development stage: Other

Overview

SkinnyRx is a telehealth platform focused on providing medical weight loss solutions through a digital-first healthcare model. The company connects patients with licensed medical providers who prescribe GLP-1 receptor agonists, such as semaglutide and tirzepatide, to manage obesity and metabolic health. Their service includes online consultations, prescription fulfillment, and ongoing clinical support to ensure patient safety and efficacy. SkinnyRx aims to simplify access to advanced weight loss medications by handling the logistics of medical screening and insurance navigation.

Therapeutic areas: Endocrinology
Modalities: PeptidesSmall molecule
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on SkinnyRx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SkinnyRx.

Explore the full profile